Berkeley Lights
In Brief This Week: Personalis, Biocartis, Opko Health, Berkeley Lights, More
News items for the week of Feb. 20, 2023.
Berkeley Lights Misses 2022 Revenue Estimates
The company blamed delayed Beacon platform placements and lower-than-expected partnership and service contract revenues for the disappointing results.
Losses Deep and Widespread as GenomeWeb Top 40 Drops 34 Percent in 2022
All but two Top 40 companies declined, with over half losing more than 50 percent of their value and 13 companies losing three-quarters of their value or more.
For proteomics firms, 2022 marked a reversal from an earlier boom, but the field pushed into emerging areas like single-cell, single-molecule, and spatial analyses.
Berkeley Lights Acquiring IsoPlexis in $57.8M All-Stock Deal
IsoPlexis shareholders will receive 0.612 shares of Berkeley Lights stock for each IsoPlexis share with the combined company taking the name PhenomeX.
Feb 24, 2022
Berkeley Lights Q4 Revenues Grow 7 Percent
Nov 4, 2021
Berkeley Lights Revenues Grow 34 Percent in Q3
Aug 11, 2021